Skip to content

Clinical trials

Cardiovascular Diseases trials in Lithuania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Country / region: Lithuania Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20092
20111
20124
20131
20161
20171
20183
20201
20211
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting4
Terminated4
Active, not recruiting1
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Eli Lilly and Company2
Heidelberg University2
P+F Products + Features GmbH2
Amgen1
Boehringer Ingelheim1
CSL Behring1
Cardurion Pharmaceuticals, Inc.1
Esperion Therapeutics, Inc.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases25
Heart Diseases7
Diabetes Mellitus, Type 26
Heart Failure6
Heart Valve Diseases4
Coronary Artery Disease3
Hypertension3
Kidney Failure, Chronic3
Stroke3
Diabetes Mellitus2

Trials

Showing 26 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.